295 related articles for article (PubMed ID: 9060683)
1. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
Lachmann RH; Efstathiou S
J Virol; 1997 Apr; 71(4):3197-207. PubMed ID: 9060683
[TBL] [Abstract][Full Text] [Related]
2. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system.
Smith C; Lachmann RH; Efstathiou S
J Gen Virol; 2000 Mar; 81(Pt 3):649-62. PubMed ID: 10675402
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency.
Berthomme H; Lokensgard J; Yang L; Margolis T; Feldman LT
J Virol; 2000 Apr; 74(8):3613-22. PubMed ID: 10729137
[TBL] [Abstract][Full Text] [Related]
4. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.
Marshall KR; Lachmann RH; Efstathiou S; Rinaldi A; Preston CM
J Virol; 2000 Jan; 74(2):956-64. PubMed ID: 10623758
[TBL] [Abstract][Full Text] [Related]
5. A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection.
Lachmann RH; Brown C; Efstathiou S
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2575-82. PubMed ID: 8887493
[TBL] [Abstract][Full Text] [Related]
6. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
[TBL] [Abstract][Full Text] [Related]
7. Long-term promoter activity during herpes simplex virus latency.
Lokensgard JR; Bloom DC; Dobson AT; Feldman LT
J Virol; 1994 Nov; 68(11):7148-58. PubMed ID: 7933097
[TBL] [Abstract][Full Text] [Related]
8. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency.
Lokensgard JR; Berthomme H; Feldman LT
J Virol; 1997 Sep; 71(9):6714-9. PubMed ID: 9261395
[TBL] [Abstract][Full Text] [Related]
9. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
10. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection.
Alvira MR; Goins WF; Cohen JB; Glorioso JC
J Virol; 1999 May; 73(5):3866-76. PubMed ID: 10196281
[TBL] [Abstract][Full Text] [Related]
11. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.
Chen X; Schmidt MC; Goins WF; Glorioso JC
J Virol; 1995 Dec; 69(12):7899-908. PubMed ID: 7494302
[TBL] [Abstract][Full Text] [Related]
12. A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics.
Maggioncalda J; Mehta A; Bagasra O; Fraser NW; Block TM
J Neurovirol; 1996 Aug; 2(4):268-78. PubMed ID: 8799218
[TBL] [Abstract][Full Text] [Related]
13. Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1.
Ecob-Prince MS; Hassan K; Denheen MT; Preston CM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1527-32. PubMed ID: 7782783
[TBL] [Abstract][Full Text] [Related]
14. Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency.
Yoshikawa T; Stanberry LR; Bourne N; Krause PR
J Virol; 1996 Mar; 70(3):1535-41. PubMed ID: 8627672
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
Arthur JL; Scarpini CG; Connor V; Lachmann RH; Tolkovsky AM; Efstathiou S
J Virol; 2001 Apr; 75(8):3885-95. PubMed ID: 11264377
[TBL] [Abstract][Full Text] [Related]
16. Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo.
Farrell MJ; Margolis TP; Gomes WA; Feldman LT
J Virol; 1994 Sep; 68(9):5337-43. PubMed ID: 8057417
[TBL] [Abstract][Full Text] [Related]
17. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
18. In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter.
Dobson AT; Margolis TP; Gomes WA; Feldman LT
J Virol; 1995 Apr; 69(4):2264-70. PubMed ID: 7884873
[TBL] [Abstract][Full Text] [Related]
19. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
[TBL] [Abstract][Full Text] [Related]
20. beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.
Huang QS; Valyi-Nagy T; Kesari S; Fraser NW
Gene Ther; 1997 Aug; 4(8):797-807. PubMed ID: 9338008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
